Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2022

Nov 1, 2022

30893_dirs_2022-11-01_00648bd5-84b0-4411-99e1-a829300bde9b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2022-10-31

Reporting Person: Wallace James H (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-10-31 Common Stock S 14000.00 $26.0391 Disposed 14709.00 Direct
2022-10-31 Common Stock M 7000.00 $18.70 Acquired 21709.00 Direct
2022-10-31 Common Stock M 7000.00 $24.21 Acquired 28709.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-10-31 Non-Employee Director Stock Option Grant $24.21 M 7000.00 Disposed 2028-05-17 Common Stock (7000.00) Direct
2022-10-31 Non-Employee Director Stock Option Grant $18.70 M 7000.00 Disposed 2027-05-18 Common Stock (7000.00) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $25.89 to $26.135. The price reported above reflects the weighted average price.